ArticleRadiation oncology (London, England)2026
Clinical impact of novel cardiovascular and immune system dosimetric parameters in stage III NSCLC patients treated with radiotherapy.
Francesco Dionisi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.